In recent years, DPP8/9 has made significant progress in the research on the mechanism of pyroptosis of blood system cells, and DPP8/9 inhibitors can be used as a potential therapeutic drug for AML. This evidence concerns the gene DPP8 and acute myeloid leukemia.